Cargando…

A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia

BACKGROUND: The real-world experience of Swiss chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) is largely unknown, in particular with regard to achievement of response per European Leukemia Net (ELN) criteria and adherence to ELN recommendations. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantoni, Nathan, Sommavilla, Roberto, Seitz, Patrick, Kulenkampff, Elisabeth, Kahn, Stefan, Lambert, Jean-François, Schmidt, Adrian, Zenhaeusern, Reinhard, Balabanov, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675134/ https://www.ncbi.nlm.nih.gov/pubmed/36402993 http://dx.doi.org/10.1186/s12885-022-10241-y

Ejemplares similares

The Epigenetic Landscape of Acute Myeloid Leukemia
por: Conway O'Brien, Emma, et al.
Publicado: (2014)

Patient‐reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis
por: Stauder, Reinhard, et al.
Publicado: (2020)

Dissecting the Immune Landscape of Acute Myeloid Leukemia
por: Davidson-Moncada, Jan, et al.
Publicado: (2018)

Functional Genomic Landscape of Acute Myeloid Leukemia
por: Tyner, Jeffrey W., et al.
Publicado: (2018)

The mutational landscape of atypical chronic myeloid leukemia
por: Langabeer, Stephen E.
Publicado: (2019)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
por: Kramer, Michael H., et al.
Publicado: (2022)

Short overview on the current treatment of chronic myeloid leukemia in chronic phase
por: Schmidt, Stefan
Publicado: (2016)

Molecular landscape and targeted therapy of acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2018)

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2020)

The clinical impact of the molecular landscape of acute myeloid leukemia
por: Kayser, Sabine, et al.
Publicado: (2023)

The modular network structure of the mutational landscape of Acute Myeloid Leukemia
por: Ibáñez, Mariam, et al.
Publicado: (2018)

Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
por: Marando, Ludovica, et al.
Publicado: (2020)

Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
por: Ahmadmehrabi, Khashayar, et al.
Publicado: (2021)

The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia
por: Xu, Binyan, et al.
Publicado: (2022)

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2023)

P424: LANDSCAPE OF CHROMATIN ACCESSIBILITY IN ACUTE MYELOID LEUKEMIA
por: Ochi, Yotaro, et al.
Publicado: (2023)

Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
por: Higgins, Alexandra, et al.
Publicado: (2020)

The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
por: Karow, Axel, et al.
Publicado: (2022)

Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape
por: Hsieh, Ya-Ching, et al.
Publicado: (2021)

Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia
por: Vanhooren, Jolien, et al.
Publicado: (2022)

Effectiveness, Adherence, and Safety of Evolocumab in a Swiss Multicenter Prospective Observational Study
por: Nanchen, David, et al.
Publicado: (2021)

P834: REAL-WORLD EVIDENCE OF SAFETY AND EFFECTIVENESS OF ECULIZUMAB AND SWITCH TO RAVULIZUMAB IN A SWISS PATIENT POPULATION WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
por: Rovó, A., et al.
Publicado: (2022)

Clinical and imaging features of myeloid sarcoma: a German multicenter study
por: Meyer, Hans-Jonas, et al.
Publicado: (2019)

Optical genome mapping in acute myeloid leukemia: a multicenter evaluation
por: Levy, Brynn, et al.
Publicado: (2022)

Molecular landscape in acute myeloid leukemia: where do we stand in 2016
por: Al-Issa, Karam, et al.
Publicado: (2016)

PB1784: CYTOGENETIC LANDSCAPE OF 87 MOROCCAN ACUTE MYELOID LEUKEMIA PATIENTS
por: Mahtat, E. M., et al.
Publicado: (2022)

PB1823: SECONDARY ACUTE MYELOID LEUKEMIA AND DE NOVO ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES DISTINCT LANDSCAPE, OR THE SAME DISEASE?
por: Jagurinoski, M., et al.
Publicado: (2022)

Adhesion molecules in acute myeloid leukemia()
por: Paietta, Elisabeth
Publicado: (1996)

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML
por: Heini, Alexander D., et al.
Publicado: (2021)

Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)—Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)
por: Rüfer, Axel, et al.
Publicado: (2022)

Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract
por: Kahn, Ryan M., et al.
Publicado: (2019)

Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies
por: Hou, Hsin-An, et al.
Publicado: (2020)

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications
por: Molina Garay, Carolina, et al.
Publicado: (2022)

Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication
por: Shahrin, Nur Hezrin, et al.
Publicado: (2022)

Genetic Landscape of Chronic Myeloid Leukemia and a Novel Targeted Drug for Overcoming Resistance
por: Yoshimaru, Ryo, et al.
Publicado: (2023)

Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A Review
por: Marrero, Richard J., et al.
Publicado: (2023)

Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions
por: Meillon-Garcia, Luis Antonio, et al.
Publicado: (2020)

Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
por: Attardi, Enrico, et al.
Publicado: (2023)

Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study
por: Yang, Xiawan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fj1dpoqb6k44la2uh4gvin3ol2